SCHEMBL30990225

SCHEMBL30990225

COC(=O)c1cc2c(n1C(=O)OC(C)(C)C)C(=O)CC2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 4/20 0.41
GPR119 Q8TDV5 2/20 0.36
ESR2 Q92731 1/20 0.34
SRD5A1 P18405 2/20 0.34
HDAC1 Q13547 2/20 0.33
UCHL1 P09936 1/20 0.32
USP30 Q70CQ3 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ELANE P08246 1/20 0.32
MAPT P10636 2/20 0.32
HDAC6 Q9UBN7 1/20 0.32
NAMPT P43490 1/20 0.32
SRD5A2 P31213 1/20 0.32
BUB1 O43683 1/20 0.32
KDM4E B2RXH2 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30990201 1.00 NR1H2 (0.41) NR1H2GPR119ESR2SRD5A1HDAC1
SCHEMBL1003642 0.80 NR1H2 (0.41) NR1H2GPR119ESR2HDAC1UCHL1
SCHEMBL24374827 0.79 GLA (0.39) GPR119NPC1RAB9AKDM4E
SCHEMBL29618505 0.79 NPC1 (0.37) NR1H2GPR119ESR2USP30NPC1
SCHEMBL7977206 0.72 NR1H2 (0.55) NR1H2HDAC1HDAC6KDM4E
SCHEMBL30990279 0.71 NR1H2 (0.37) NR1H2GPR119ESR2HDAC1
SCHEMBL1004859 0.70 NR1H2 (0.40) NR1H2HDAC1UCHL1USP30ELANE
SCHEMBL16115882 0.69 NR1H2 (0.40) NR1H2GPR119HDAC1UCHL1USP30
SCHEMBL18537881 0.68 NR1H2 (0.53) NR1H2
SCHEMBL30853473 0.68 ALDH1A1 (0.49) NR1H2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626860-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS ReWind Therapeutics NV (BE) 2025-10-08 EP disclosed
WO-2024115733-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS REWIND THERAPEUTICS NV (BE) 2024-06-06 WO disclosed